Long-term use of everolimus in lung transplant patients

Transplantation Proceedings

Volumn 43, Issue 6, 2011, Pages 2313-2315

  Parada, M T ^a   Alba, A ^a   Sepulveda C ^a   Melo, J ^a  

^a Centro de Trasplante Cínica Las Condes   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CREATININE; EVEROLIMUS; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STEROID; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ARTICLE; BRONCHIOLITIS OBLITERANS; BRONCHITIS; CLINICAL ARTICLE; CREATININE CLEARANCE; DEATH; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; DYSLIPIDEMIA; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GRAFT RECIPIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY FUNCTION; LUNG FIBROSIS; LUNG FUNCTION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; LUNG TUBERCULOSIS; LYMPHOMA; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SIDE EFFECT; SKIN CANCER; TREATMENT INDICATION; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; CHILE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 80051679646     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.06.010     Document Type: Article

References (12)

1. J.K. Patel, and J.A. Kobashigawa Everolimus: an immunosuppressive agent in transplantation Expert Opin Pharmacother 7 2006 1347
2. S. Flechner, J. Kobashigawa, and G. Klintmalm Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity Clin Transplant 22 2008 1
3. H. Eisen, E. Tuzcu, and R. Dorent Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients N Engl J Med 349 2003 847
4. V.N. Lama Update in lung transplantation 2008 Am J Respir Crit Care Med 1 2009 179 759
5. P.M. Hopkins, and K. McNeil Evidence for immunosuppression in lung transplantation Curr Opin Organ Transplant 13 2008 477
6. M.T. Parada, A. Alba, and C. Sepúlveda Everolimus in lung transplantation in Chile Transplant Proc 42 2010 328
7. L. Gullestad, S.A. Mortensen, and H. Eiskjær Two-year outcomes in thoracic transplant recipients after conversion to everolimus with reduced calcineurin inhibitor within a multicenter, open-label, randomized trial Transplantation 90 2010 1581
8. G. Snell, V. Valentine, and P. Vitulo Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double-blind clinical trial Am J Transplant 6 2006 169
9. J. Morales, D. Benavente, and A. Fierro Conversion from a calcineurin inhibitor based immunosuppression Regimen to Everolimus in renal transplant recipients: effect on renal patients with proteinuria Transplant Proc 39 2007 591
10. M. Ayala, J. Morales, and A. Fierro Metabolic changes following conversion from an anticalcineurinic based therapy to an everolimus based one A single center experience Transplant Proc 40 2008 3265
11. M. Lorber, C. Ponticelli, and J. Whelchel Therapeutic drug monitoring for everolimus in kidney transplantation using 12-month exposure, efficacy, and safety data Clin Transplant 19 2005 145
12. J. Pascal, R. Marce, and J. Ortuo Clinical experience with everolimus (Certican): optimizing dose and tolerability Transplantation 79 2005 S80